Advertisement

Ceftazidime Injection

[21 May 2015]

Products Affected - Description

Ceftazidime vials
Ceftazidime injection, Sagent
1 gm vials, packages of 25 (NDC 25021-0127-20)
2 gm vials, packages of 10 (NDC 25021-0128-50)
 
Ceftazidime injection, Sandoz
1 gm vials, packages of 25 (NDC 00781-3177-96)
2 gm, vials, packages of 10 (NDC 00781-3178-95)
 
Ceftazidime injection, WG Critical Care
1 gram vials, package of 25 (NDC 44567-0235-25)
 
Fortaz injection, Covis
6 gm vials, packages of 6 (NDC 24987-0382-37)

Ceftazidime premixed bags

There are no presentations affected.

Reason for the Shortage

  • Covis had Fortaz premixed bags on shortage due to increased demand.
  • Hospira had ceftazidime on shortage due to manufacturing delays.
  • Sagent has ceftazidime injection on shortage due to manufacturing delays.

Available Products

Ceftazidime vials
Fortaz injection, Covis
500 mg vials, packages of 10 (NDC 24987-0377-10)
1 gm vials, package of 10 (NDC 24987-0378-10)
1 gm TwistVials, packages of 25 (NDC 24987-0434-00)
2 gm vials, packages of 10 (NDC 24987-0379-34)
2 gm TwistVials, packages of 10 (NDC 24987-0435-00)

Tazicef injection, Hospira
1 gm vials, packages of 25 (NDC 00409-5082-16)
1 gm ADD-Vantage vials, packages of 25 (NDC 00409-5092-16)
2 gm vials, packages of 10 (NDC 00409-5084-11)
2 gm ADD-Vantage vials, packages of 10 (NDC 00409-5093-11)
6 gm vials, packages of 10 (NDC 00409-5086-11)
 
Ceftazidime injection, Sagent
6 gm vials, packages of 6 (NDC 25021-0129-99)
 
Ceftazidime injection, Sandoz
6 gm vials, packages of 6 (NDC 00781-3179-86)
 
Ceftazidime injection, WG Critical Care
2 gram vials, package of 10 (NDC 44567-0236-10)
6 gram vials, package of 6 (NDC 44567-02375-06)

Ceftazidime premixed bags
Ceftazidime injection, B. Braun Medical
1 gm/50 mL premixed bag (NDC 00264-3143-11)
2 gm/50 mL premixed bag (NDC 00264-3145-11)
 
Fortaz solution, Covis
1 gm/50 mL premixed bag (NDC 24987-0412-00)
2 gm/50 mL premixed bag (NDC 24987-0413-00)

Estimated Resupply Dates

  • Covis has Fortaz 6 gram vials on back order and the company cannot estimate a released date.
  • Sagent has ceftazidime 1 gram vials on back order and the company cannot estimate a release date. The 2 gram vials are on allocation.
  • Sandoz has ceftazidime injection 1 gram vials on back order and the company estimates a release date of late-May 2015. Ceftazidime 2 gram vials are on back order and the company estimates a release date of late-June 2015.
  • WG Critical Care has ceftazidime injection 1 gram vials on back order and the company estimates a release date in early-June 2015. Check with your wholesaler for inventory.

Related Shortages

Updated

May 5 and 21, April 8 and 27, March 3, February 9 and 20, January 7 and 23, 2015; December 1, 17, and 22, November 4 and 21, October 3, September 5, August 1 and 15, July 3 and 17, June 3 and 24, April 2 and 24, March 3, February 24, January 6 and 24, 2014; December 4 and 20, November 13, October 10 and 14, August 1, 29, and 30, July 11 and 18, June 13, May 20, April 17 and 24, March 8, February 13, January 14 and 28, 2013; December 10 and 24, November 16 and 30, October 22, September 6, 17, and 27, August 9, July 5 and 25, June 1 and 12, May 16, April 24, March 30, February 8, January 10, 2012; December 21, November 29, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement